P40: Difference between revisions

(12 intermediate revisions by the same user not shown)

Line 1:

'''p40''' an [[immunostain]] that is both [[sensitivity|sensitive]] and [[specificity|specific]] for [[squamous cell carcinoma]].

{{ Infobox immunostain

| Name = {{PAGENAME}}

| Image = Consistent with HPV-associated SCC - p40 -- high mag.jpg

| Width =

| Caption = p40 immunostain in [[squamous cell carcinoma]].

| Abbrev =

| Synonyms =

| Similar = [[p63]] - less specific for [[squamous carcinoma]] than p40

| Clones =

| Use = lung (adenocarcinoma vs. squamous)

| Subspecial =

| Pattern = nuclear staining

| Positive = [[squamous cell carcinoma]], [[urothelial carcinoma]]

| Negative = [[prostate carcinoma]], most [[lung adenocarcinoma]], most breast carcinoma

| Other =

}}

'''p40''' an [[immunostain]] that is both [[sensitivity|sensitive]] and [[specificity|specific]] for [[squamous cell carcinoma]]. Like other "p" immunostains (e.g. p16, p63), it is a nuclear stain.

==General==

*Considered superior to [[p63]] as it is more [[specificity|specific]].<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref>

*Considered superior to [[p63]] as it is more [[specificity|specific]].<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref><ref name=pmid25263848>{{Cite journal | last1 = Alomari | first1 = AK. | last2 = Glusac | first2 = EJ. | last3 = McNiff | first3 = JM. | title = p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma. | journal = J Cutan Pathol | volume = 41 | issue = 11 | pages = 839-45 | month = Nov | year = 2014 | doi = 10.1111/cup.12388 | PMID = 25263848 }}</ref>

**p63 stains a significant number of adenocarcinoma.

**p63 stains a significant number of [[adenocarcinoma]]s.

==Staining==

===Positive===

*[[Squamous cell carcinoma of the lung]].

*[[Urothelial carcinoma]].<ref name=pmid24711443>{{Cite journal | last1 = Brandler | first1 = TC. | last2 = Aziz | first2 = MS. | last3 = Rosen | first3 = LM. | last4 = Bhuiya | first4 = TA. | last5 = Yaskiv | first5 = O. | title = Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens. | journal = Cancer Cytopathol | volume = 122 | issue = 6 | pages = 468-73 | month = Jun | year = 2014 | doi = 10.1002/cncy.21424 | PMID = 24711443 }}</ref>

====Images====

Image: Consistent with HPV-associated SCC - p40 -- intermed mag.jpg | c/w HPV-SCC - p40 - intermed. mag. (WC/Nephron)

Image: Consistent with HPV-associated SCC - p40 -- high mag.jpg | c/w HPV-SCC - p40 - high mag. (WC/Nephron)

</gallery>

===Negative===

*[[Lung adenocarcinoma]].

*Breast carcinoma.

**CK5 +ve breast carcinomas are typically p40 positive.<ref name=pmid26330357>{{Cite journal | last1 = Kővári | first1 = B. | last2 = Szász | first2 = AM. | last3 = Kulka | first3 = J. | last4 = Marušić | first4 = Z. | last5 = Šarčević | first5 = B. | last6 = Tiszlavicz | first6 = L. | last7 = Cserni | first7 = G. | title = Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions. | journal = Pathobiology | volume = 82 | issue = 3-4 | pages = 166-71 | month = Sep | year = 2015 | doi = 10.1159/000375127 | PMID = 26330357 }}</ref>

*[[Prostate carcinoma]].<ref name=pmid25852959>{{Cite journal | last1 = Brustmann | first1 = H. | title = p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12. | journal = Patholog Res Int | volume = 2015 | issue = | pages = 897927 | month = | year = 2015 | doi = 10.1155/2015/897927 | PMID = 25852959 }}</ref>

==See also==

@@ Line 1: / Line 1: @@
-'''p40''' an [[immunostain]] that is both [[sensitivity|sensitive]] and [[specificity|specific]] for [[squamous cell carcinoma]].
+{{ Infobox immunostain
+| Name       = {{PAGENAME}}
+| Image      = Consistent with HPV-associated SCC - p40 -- high mag.jpg
+| Width      =
+| Caption    = p40 immunostain in [[squamous cell carcinoma]].
+| Abbrev     =
+| Synonyms   =
+| Similar    = [[p63]] - less specific for [[squamous carcinoma]] than p40
+| Clones     =
+| Use        = lung (adenocarcinoma vs. squamous)
+| Subspecial =
+| Pattern    = nuclear staining
+| Positive   = [[squamous cell carcinoma]], [[urothelial carcinoma]]
+| Negative   = [[prostate carcinoma]], most [[lung adenocarcinoma]], most breast carcinoma
+| Other      =
+}}
+'''p40''' an [[immunostain]] that is both [[sensitivity|sensitive]] and [[specificity|specific]] for [[squamous cell carcinoma]]. Like other "p" immunostains (e.g. p16, p63), it is a nuclear stain.
 ==General==
-*Considered superior to [[p63]] as it is more [[specificity|specific]].<ref name=pmid22056955>{{Cite journal  | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref>
+*Considered superior to [[p63]] as it is more [[specificity|specific]].<ref name=pmid22056955>{{Cite journal  | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref><ref name=pmid25263848>{{Cite journal  | last1 = Alomari | first1 = AK. | last2 = Glusac | first2 = EJ. | last3 = McNiff | first3 = JM. | title = p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma. | journal = J Cutan Pathol | volume = 41 | issue = 11 | pages = 839-45 | month = Nov | year = 2014 | doi = 10.1111/cup.12388 | PMID = 25263848 }}</ref>
-**p63 stains a significant number of adenocarcinoma.
+**p63 stains a significant number of [[adenocarcinoma]]s.
 ==Staining==
 ===Positive===
 *[[Squamous cell carcinoma of the lung]].
+*[[Urothelial carcinoma]].<ref name=pmid24711443>{{Cite journal  | last1 = Brandler | first1 = TC. | last2 = Aziz | first2 = MS. | last3 = Rosen | first3 = LM. | last4 = Bhuiya | first4 = TA. | last5 = Yaskiv | first5 = O. | title = Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens. | journal = Cancer Cytopathol | volume = 122 | issue = 6 | pages = 468-73 | month = Jun | year = 2014 | doi = 10.1002/cncy.21424 | PMID = 24711443 }}</ref>
+====Images====
+<gallery>
+Image: Consistent with HPV-associated SCC - p40 -- intermed mag.jpg | c/w HPV-SCC - p40 - intermed. mag. (WC/Nephron)
+Image: Consistent with HPV-associated SCC - p40 -- high mag.jpg | c/w HPV-SCC - p40 - high mag. (WC/Nephron)
+</gallery>
 ===Negative===
 *[[Lung adenocarcinoma]].
+*Breast carcinoma.
+**CK5 +ve breast carcinomas are typically p40 positive.<ref name=pmid26330357>{{Cite journal  | last1 = Kővári | first1 = B. | last2 = Szász | first2 = AM. | last3 = Kulka | first3 = J. | last4 = Marušić | first4 = Z. | last5 = Šarčević | first5 = B. | last6 = Tiszlavicz | first6 = L. | last7 = Cserni | first7 = G. | title = Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions. | journal = Pathobiology | volume = 82 | issue = 3-4 | pages = 166-71 | month = Sep | year = 2015 | doi = 10.1159/000375127 | PMID = 26330357 }}</ref>
+*[[Prostate carcinoma]].<ref name=pmid25852959>{{Cite journal  | last1 = Brustmann | first1 = H. | title = p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12. | journal = Patholog Res Int | volume = 2015 | issue =  | pages = 897927 | month =  | year = 2015 | doi = 10.1155/2015/897927 | PMID = 25852959 }}</ref>
 ==See also==

P40: Difference between revisions

Navigation menu

Search